Literature DB >> 17551979

Temporal and spatial profiles of cell loss after spinal cord injury: Reduction by a metalloporphyrin.

Xiang Ling1, Danxia Liu.   

Abstract

This study presents quantitative temporal and spatial profiles of neuronal loss and apoptosis following a contusion spinal cord injury (50 g . cm). The profiles were evaluated by counting the cresol violet-stained surviving cells and the total number of TUNEL-positive cells and of TUNEL-positive neurons in sections 0- 4 mm from the epicenter and 1, 6, 12, 24, 48, and 72 hr and 1 week postinjury. We demonstrated that neurons continue to disappear over 1 week postinjury and that neuronal loss shifts to areas longer distances from the epicenter over time. TUNEL-positive cells in both gray and white matter appeared after 6 hr, gradually increased to a peak level after 48 hr, and declined by 72 hr postinjury. TUNEL-positive neurons peaked earlier and were present for 1 week, although the total number of neurons was reduced significantly by the end of the week. The neuronal loss and apoptosis were partially prevented by a metalloporphyrin [Mn(III) tetrakis (4-benzoic acid) porphyrin (MnTBAP)]. We demonstrated that MnTBAP (10 and 50 mg/kg, given intraperitoneally) significantly reduced neuronal death in the sections 1-2.5 mm rostral and 1 mm caudal from the epicenter compared with that in the vehicle-treated group, suggesting MnTBAP is more effective in the sections rostral than in those caudal to the epicenter. MnTBAP (10 mg/kg) significantly reduced the number of TUNEL-positive neurons in the sections 1 mm caudal from the epicenter. Our profiles provide a database for pharmacological intervention, and our results on MnTBAP treatment support an important role for antioxidant therapy in spinal cord injury. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551979     DOI: 10.1002/jnr.21362

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  17 in total

1.  Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Authors:  Liqin Wu; Yichu Shan; Danxia Liu
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

Review 2.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats.

Authors:  Anshu Chen; Melanie L McEwen; Shixin Sun; Rangaswamyrao Ravikumar; Joe E Springer
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

4.  Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.

Authors:  T Celic; J Španjol; M Bobinac; A Tovmasyan; I Vukelic; J S Reboucas; I Batinic-Haberle; D Bobinac
Journal:  Free Radic Res       Date:  2014-10-10

5.  Hydrogen peroxide administered into the rat spinal cord at the level elevated by contusion spinal cord injury oxidizes proteins, DNA and membrane phospholipids, and induces cell death: attenuation by a metalloporphyrin.

Authors:  D Liu; F Bao
Journal:  Neuroscience       Date:  2014-11-05       Impact factor: 3.590

6.  Mn (III) tetrakis (4-benzoic acid) porphyrin protects against neuronal and glial oxidative stress and death after spinal cord injury.

Authors:  Lokanatha Valluru; Yao Diao; Jorge E Hachmeister; Danxia Liu
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

7.  Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury.

Authors:  Sarah A Figley; Ramak Khosravi; Jean M Legasto; Yun-Fan Tseng; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2014-01-11       Impact factor: 5.269

Review 8.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

9.  Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone.

Authors:  Danxia Liu; Yichu Shan; Lokanatha Valluru; Feng Bao
Journal:  BMC Neurosci       Date:  2013-03-01       Impact factor: 3.288

Review 10.  Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.

Authors:  Artak Tovmasyan; Huaxin Sheng; Tin Weitner; Amanda Arulpragasam; Miaomiao Lu; David S Warner; Zeljko Vujaskovic; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Med Princ Pract       Date:  2012-10-16       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.